Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever

G. Horneff, N. Ruperto, H. Brunner, P. Quartier, T. Constantin, E. Alexeeva, I. Kone-Paut, K. Marzan, N. Wulffraat, R. Schneider, S. Padeh, V. Chasnyk, C. Wouters, J. Kummerle Deschner, T. Kallinich, B. Lauwerys, E. Haddad, E. Nasonov, M. Trachana, O. VougioukaK. Abrams, K. Leon, K. Lheritier, A. Martini, D. Lovell

Research output: Article

Original languageEnglish
Article numberO83
JournalPediatric Rheumatology
Volume13
Issue number1
DOIs
Publication statusPublished - szept. 28 2015

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Rheumatology
  • Immunology and Allergy

Cite this

Horneff, G., Ruperto, N., Brunner, H., Quartier, P., Constantin, T., Alexeeva, E., Kone-Paut, I., Marzan, K., Wulffraat, N., Schneider, R., Padeh, S., Chasnyk, V., Wouters, C., Deschner, J. K., Kallinich, T., Lauwerys, B., Haddad, E., Nasonov, E., Trachana, M., ... Lovell, D. (2015). Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever. Pediatric Rheumatology, 13(1), [O83]. https://doi.org/10.1186/1546-0096-13-S1-O83